☆ 4.7 Article

Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-a-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation

EBIOMEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

Nicholas A. Kennedy et al.

Summary: This study found that a third dose of an mRNA-based vaccine can boost antibody responses and immunity in infliximab-treated patients with IBD. However, these patients had lower antibody concentrations compared to those treated with vedolizumab and were more likely to experience breakthrough infections and reinfections.

GUT (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Neutralising antibody potency against SARS-CoV-2 wild- type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu et al.

Summary: This study aimed to determine the impact of the anti-TNF drug infliximab and the anti-integrin drug vedolizumab on vaccine-induced neutralising antibodies against the omicron variant of SARS-CoV-2. The results showed that patients treated with infliximab had significantly lower antibody levels after three doses of vaccine compared to those treated with vedolizumab, and they also had a higher risk of breakthrough infection.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Letter Allergy

Omicron: A SARS-CoV-2 variant of real concern

Pia Gattinger et al.

ALLERGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

Katharina Roltgen et al.

Summary: During the SARS-CoV-2 pandemic, different vaccines have been used globally. This study compares the antibodies generated by mRNA vaccines, infection, and other types of vaccines. It shows that mRNA vaccines result in a better antibody breadth against viral variants compared to infection. Infection leads to variant-specific antibodies, while mRNA vaccination imprints responses towards the original virus strain. mRNA vaccines also stimulate robust germinal centers in lymph nodes, enhancing the immune response.

CELL (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation

Raffi Lev-Tzion et al.

Summary: COVID-19 vaccine effectiveness in IBD patients is comparable to non-IBD controls and is not affected by treatment with TNF inhibitors or corticosteroids. The risk of IBD exacerbation did not differ between vaccinated and unvaccinated patients.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

James L. Alexander et al.

Summary: The study found that the immunogenicity of COVID-19 vaccines varies in patients with inflammatory bowel disease (IBD) depending on the immunosuppressive drugs they are on. Patients treated with infliximab, infliximab plus thiopurines, and tofacitinib had lower antibody concentrations, while there were no significant differences in patients treated with thiopurines, ustekinumab, and vedolizumab compared to healthy controls.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic

Simeng Lin et al.

Summary: This review summarizes the risk and outcomes of COVID-19 in patients with IBD, as well as the latest guidance on SARS-CoV-2 vaccines. Certain medications may be associated with adverse outcomes to COVID-19, while a decrease in endoscopy procedures has led to missed cancer cases.

GUT (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy

Dalin Li et al.

Summary: There is a poor correlation between T-cell and antibody responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients. Most biologic therapies preserve T-cell responses, but anti-tumor necrosis factor (anti-TNF) treatment enhances T-cell responses. While anti-TNF therapy dampens antibody response, cellular immunity remains robust after vaccination.

INFLAMMATORY BOWEL DISEASES (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients

Karin Cerna et al.

Summary: Limited knowledge on the immunogenicity of anti-SARS-CoV-2 vaccines in inflammatory bowel disease (IBD) patients. It was found that there was a more significant decrease in antibody levels in the IBD cohort compared to the healthy cohort after vaccination. Additionally, the overall functional ability of T-lymphocytes to produce interferon-gamma was lower in IBD patients. Repeated vaccine doses may be scheduled for IBD patients based on simple humoral and cellular post-vaccination monitoring.

JOURNAL OF CROHNS & COLITIS (2022)

添加到收藏夹

Article Immunology

Antibody secreting cells are critically dependent on integrin α4β7/MAdCAM-1 for intestinal recruitment and control of the microbiota during chronic colitis

Christopher J. Tyler et al.

Summary: The study demonstrated that under inflammatory conditions, B cells mainly rely on integrin alpha 4 beta 7 for homing to the intestine, and deficiency in beta 7 and blockade of MAdCAM-1 can lead to severe colitis and alterations in microbiota composition. The deficit in IgA is closely associated with aggravated colitis.

MUCOSAL IMMUNOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin et al.

Summary: This study reports immune responses and breakthrough infections in patients with inflammatory bowel disease receiving anti-TNF treatments after receiving COVID-19 vaccination, and suggests the need for adapted vaccination schedules for these patients.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Preserved SARS-CoV-2 Vaccine Cell-Mediated Immunogenicity in Patients With Inflammatory Bowel Disease on Immune-Modulating Therapies

Brigid S. Boland et al.

Summary: This study assessed the differences in SARS-CoV-2 vaccine immunogenicity between patients with IBD treated with different immune-modulating medications and normal healthy donors. The results showed reduced humoral immunity in patients with IBD on infliximab, but no difference in humoral and cell-mediated immunity in patients with IBD on infliximab with a thiopurine or vedolizumab compared with normal healthy donors.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2022)

添加到收藏夹

Article Immunology

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease

Angelika Wagner et al.

Summary: This study investigated the persistence and anamnestic responses following SARS-CoV-2 mRNA vaccinations in individuals with secondary immunodeficiencies. The results suggest that primary mRNA vaccination can induce antibody responses, but some patients may experience a decline in antibody levels. Booster vaccination significantly increases antibody levels and induces anamnestic responses, but certain medications may affect the antibody response.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA-vaccinated with bowel disease

Kathryn A. Pape et al.

Summary: Immunosuppressed patients with inflammatory bowel disease (IBD) generate lower amounts of SARS-CoV-2 spike antibodies after mRNA vaccination than healthy controls. Defects in antibody-secreting B cells and affinity-matured memory B cells in IBD patients can be corrected by a third vaccination.

JCI INSIGHT (2022)

添加到收藏夹

Letter Allergy

Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding

Pia Gattinger et al.

ALLERGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Jennifer M. Dan et al.

Summary: Different components of immune memory to SARS-CoV-2 exhibit distinct kinetics, with antibodies and spike-specific memory B cells remaining relatively stable over 6 months, while CD4(+) T cells and CD8(+) T cells declining with a half-life of 3 to 5 months after infection.

SCIENCE (2021)

添加到收藏夹

Article Microbiology

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals

Jian Zhang et al.

Summary: COVID-19 is caused by SARS-CoV-2, and the majority of convalescent individuals maintain neutralizing antibodies against SARS-CoV-2. Those who experienced severe COVID-19 had higher levels of neutralizing antibodies, a faster increase in lymphocyte counts, and a higher frequency of CXCR3(+) T-follicular help cells.

NATURE MICROBIOLOGY (2021)

添加到收藏夹

Review Cell Biology

Vedolizumab: Potential Mechanisms of Action for Reducing Pathological Inflammation in Inflammatory Bowel Diseases

Matthew Luzentales-Simpson et al.

Summary: Inflammatory bowel diseases are characterized by chronic inflammation along the gastrointestinal tract due to excessive leukocyte infiltration. Current treatments include aminosalicylates, corticosteroids, immunosuppressants, and biologics such as anti-TNF antibodies, although some patients may become unresponsive to anti-TNF therapy.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Review Immunology

Antigen-dependent multistep differentiation of T-follicular helper cells and its role in SARS-CoV-2 infection and vaccination

Dirk Baumjohann et al.

Summary: Tfh cells are essential for potent humoral immune responses, and their differentiation and memory maintenance are influenced by various factors, including interactions with APCs, costimulatory and coinhibitory pathways, and cytokines. Understanding the differentiation and memory maintenance of Tfh cells is crucial for a deeper understanding of immune responses and vaccine development.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Nicholas A. Kennedy et al.

Summary: Infliximab treatment in patients with inflammatory bowel disease results in attenuated serological responses to a single dose of the SARS-CoV-2 vaccine. Delayed second dosing should be avoided in these patients, as vaccination after SARS-CoV-2 infection or a second dose leads to seroconversion in most individuals.

GUT (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges

Judith Wellens et al.

Summary: Patients with inflammatory bowel diseases (IBD) have been considered high-risk for COVID-19 infection and complications since the start of the pandemic. However, they were excluded from clinical phase III vaccine trials, leading to challenges in assessing the effectiveness of new vaccines. Adapted vaccination strategies may be needed for some IBD patients to optimize immune response. Therefore, further research is needed to develop tailored vaccination plans for IBD patients.

JOURNAL OF CROHNS & COLITIS (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Review Article: Vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic

Jayne Doherty et al.

Summary: Patients with IBD have reduced immune responses following vaccination, especially when receiving anti-TNF therapy which may decrease antibody titres to COVID-19 vaccines. It is recommended that IBD patients be vaccinated at the earliest opportunity, ideally in remission with minimized corticosteroid dose before vaccination. Further research is needed to explore the impact of different biologics on vaccine response to COVID-19 in the IBD population and the potential for booster vaccines or heterologous prime-boost vaccinations.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

NKT cells and the regulation of intestinal immunity: a two-way street

Phillip M. Brailey et al.

FEBS JOURNAL (2020)

添加到收藏夹

Article Immunology

Obesity and Sex Affect the Immune Responses to Tick-Borne Encephalitis Booster Vaccination

Erika Garner-Spitzer et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease

Bahez Gareb et al.

PHARMACEUTICS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Naoki Kaneko et al.

CELL (2020)

添加到收藏夹

Review Medicine, General & Internal

Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?

Raja Atreya et al.

FRONTIERS IN MEDICINE (2020)

添加到收藏夹

Review Medicine, General & Internal

Pathophysiology of Inflammatory Bowel Diseases

John T. Chang

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Immunology

Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination

Johanna E. Huber et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study

Suresh Pallikkuth et al.

PLOS BIOLOGY (2019)

添加到收藏夹

Review Immunology

Targeting immune cell circuits and trafficking in inflammatory bowel disease

Markus F. Neurath

NATURE IMMUNOLOGY (2019)

添加到收藏夹

Article Immunology

TNF-α Contributes to Lymphoid Tissue Disorganization and Germinal Center B Cell Suppression during Intracellular Bacterial Infection

Maria Popescu et al.

JOURNAL OF IMMUNOLOGY (2019)

添加到收藏夹

Review Immunology

Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations

Ignacio Sanz et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Cell Biology

Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity

Marios Koutsakos et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules

Angelika Wagner et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Article Medicine, General & Internal

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

Siew C. Ng et al.

LANCET (2017)

添加到收藏夹

Article Immunology

Human Circulating T Follicular Helper Cell Subsets in Health and Disease

Hideki Ueno

JOURNAL OF CLINICAL IMMUNOLOGY (2016)

添加到收藏夹

Article Cell Biology

Severe Malaria Infections Impair Germinal Center Responses by Inhibiting T Follicular Helper Cell Differentiation

Victoria Ryg-Cornejo et al.

CELL REPORTS (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

V. Jairath et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases

Zhe Li et al.

INFLAMMATORY BOWEL DISEASES (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

R. Khanna et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

添加到收藏夹

Review Immunology

Roles of ligands from the TNF superfamily in B cell development, function, and regulation

William A. Figgett et al.

SEMINARS IN IMMUNOLOGY (2014)

添加到收藏夹

Review Immunology

Migration, maintenance and recall of memory T cells in peripheral tissues

David L. Woodland et al.

NATURE REVIEWS IMMUNOLOGY (2009)

添加到收藏夹

Article Immunology

Cutting edge: Anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks

Jennifer H. Anolik et al.

JOURNAL OF IMMUNOLOGY (2008)

添加到收藏夹

Review Immunology

Understanding the generation and function of memory T cell subsets

A Lanzavecchia et al.

CURRENT OPINION IN IMMUNOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.